$IPWR
Ideal Power Inc.

2015 Q2 Form 10-Q Financial Statement

#000114420415027790 Filed on May 06, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2014 Q1
Revenue $1.199M $1.198M $291.1K
YoY Change 113.91% 311.55% -23.42%
Cost Of Revenue $1.056M $1.020M $397.2K
YoY Change 85.18% 156.66% -7.47%
Gross Profit $142.9K $178.5K -$106.1K
YoY Change -1556.96% -268.18% 115.92%
Gross Profit Margin 11.92% 14.9% -36.46%
Selling, General & Admin $1.340M $1.384M $1.013M
YoY Change 36.72% 36.57% 120.26%
% of Gross Profit 937.44% 775.24%
Research & Development $1.100M $992.2K $310.0K
YoY Change 70.51% 220.07% 32.28%
% of Gross Profit 770.02% 555.9%
Depreciation & Amortization $50.00K $32.80K $9.084K
YoY Change 400.0% 261.11% 62.85%
% of Gross Profit 34.99% 18.38%
Operating Expenses $2.440M $2.376M $1.323M
YoY Change 50.14% 79.62% 91.17%
Operating Profit -$2.297M -$2.197M -$1.429M
YoY Change 40.5% 53.79% 92.81%
Interest Expense $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0% -100.93%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.290M -$2.190M -$1.420M
YoY Change 40.49% 54.23% -21.98%
Income Tax
% Of Pretax Income
Net Earnings -$2.292M -$2.193M -$1.421M
YoY Change 40.85% 54.36% -22.13%
Net Earnings / Revenue -191.19% -183.06% -488.07%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.827M -$3.085M -$2.029M
COMMON SHARES
Basic Shares Outstanding 7.085M shares 7.066M shares 7.011M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.97M $6.170M $12.44M
YoY Change 79.1% -50.4% 919.67%
Cash & Equivalents $19.97M $6.169M $12.44M
Short-Term Investments
Other Short-Term Assets $290.0K $260.0K $230.0K
YoY Change 70.59% 13.04% 475.0%
Inventory $670.0K $234.0K $507.6K
Prepaid Expenses
Receivables $760.0K $833.5K $340.4K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $21.68M $7.501M $13.52M
YoY Change 81.12% -44.53% 663.99%
LONG-TERM ASSETS
Property, Plant & Equipment $620.0K $496.5K $117.0K
YoY Change 100.0% 324.23% 290.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $17.92K $17.92K $35.84K
YoY Change -55.2% -50.0%
Total Long-Term Assets $1.725M $1.538M $896.5K
YoY Change 43.76% 71.58% 60.08%
TOTAL ASSETS
Total Short-Term Assets $21.68M $7.501M $13.52M
Total Long-Term Assets $1.725M $1.538M $896.5K
Total Assets $23.41M $9.039M $14.42M
YoY Change 77.72% -37.31% 518.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.150M $687.4K $322.2K
YoY Change 238.24% 113.35% -19.45%
Accrued Expenses $880.0K $1.017M $460.2K
YoY Change 49.15% 121.04% 119.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $2.040M $1.705M $782.4K
YoY Change 119.35% 117.87% -74.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.040M $1.705M $782.4K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.040M $1.700M $780.0K
YoY Change 119.35% 117.95% -81.43%
SHAREHOLDERS EQUITY
Retained Earnings -$28.14M -$25.85M -$18.17M
YoY Change 42.22%
Common Stock $9.345K $7.066K $7.011K
YoY Change 0.78%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.657K $2.657K $2.657K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $21.37M $7.334M $13.64M
YoY Change
Total Liabilities & Shareholders Equity $23.41M $9.039M $14.42M
YoY Change 77.72% -37.31% 518.85%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$2.292M -$2.193M -$1.421M
YoY Change 40.85% 54.36% -22.13%
Depreciation, Depletion And Amortization $50.00K $32.80K $9.084K
YoY Change 400.0% 261.11% 62.85%
Cash From Operating Activities -$1.890M -$1.590M -$1.520M
YoY Change 92.86% 4.61% 111.11%
INVESTING ACTIVITIES
Capital Expenditures -$300.0K $150.3K $37.26K
YoY Change -3.23% 303.51% 765.68%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$300.0K -$240.0K -$180.0K
YoY Change -3.23% 33.33% 200.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.99M 80.00K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -1.890M -1.590M -1.520M
Cash From Investing Activities -300.0K -240.0K -180.0K
Cash From Financing Activities 15.99M 80.00K 0.000
Net Change In Cash 13.80M -1.750M -1.700M
YoY Change -1169.77% 2.94% 123.68%
FREE CASH FLOW
Cash From Operating Activities -$1.890M -$1.590M -$1.520M
Capital Expenditures -$300.0K $150.3K $37.26K
Free Cash Flow -$1.590M -$1.740M -$1.557M
YoY Change 137.31% 11.76% 115.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
7066 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
7048 USD
CY2015Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33175444 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32712020 USD
CY2015Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2657 USD
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2657 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25845429 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23652431 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
7334424 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
9063980 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9039057 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10278735 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1704633 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1214755 USD
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7912011 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6169375 USD
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
833470 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
446521 USD
CY2015Q1 us-gaap Inventory Net
InventoryNet
233961 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
251338 USD
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
264090 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
263605 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
7500896 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
8873475 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
496473 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
374376 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1023768 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1012964 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17920 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17920 USD
CY2015Q1 us-gaap Assets
Assets
9039057 USD
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
687404 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
441636 USD
CY2015Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1017229 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
773119 USD
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2951294 shares
CY2015Q1 us-gaap Property Plant And Equipment Depreciation Methods
PropertyPlantAndEquipmentDepreciationMethods
straight-line method
CY2014Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
132227 USD
CY2015Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <u>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The preparation of financial statements in conformity with US GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q1 ipwr Research And Development Expense Including Grants
ResearchAndDevelopmentExpenseIncludingGrants
512446 USD
CY2015Q1 ipwr Research And Development Expense Including Grants
ResearchAndDevelopmentExpenseIncludingGrants
992232 USD
CY2014Q1 ipwr Research And Development Expense Grants
ResearchAndDevelopmentExpenseGrants
202883 USD
CY2015Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2400663 shares
CY2014Q1 us-gaap Revenue From Grants
RevenueFromGrants
182595 USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1197991 USD
CY2015Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <u>Concentration of Credit Risk</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash, accounts receivable and accounts payable. The Company maintains its cash with a major financial institution located in the United States. Balances are insured by the Federal Deposit Insurance Corporation up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>. The Company maintains balances in excess of federally insured limits. The Company has not experienced losses in such accounts and believes it is not exposed to significant credit risk regarding its cash and cash equivalents.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The Company encounters a certain amount of risk as a result of a concentration of revenue from a few significant customers. Credit is extended to customers based on an evaluation of their financial condition. In limited instances, the Company may require an upfront deposit and, in most cases, the Company does charge interest on past due amounts. The Company performs ongoing credit evaluations of its customers and records an allowance for potential bad debts based on available information.&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The Company had revenue from three customers which accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 51</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 13</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 13</font>% of net revenue for the three months ended March 31, 2015 and revenue from a customer which accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 33</font>% of net revenue for the three months ended March 31, 2014. The Company also had revenue from a government entity that accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 63</font>% of net revenue for the three months ended March 31, 2014.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> The Company had receivable balances from two customers that accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 72</font></font>% of trade receivables at March 31, 2015. The Company had receivable balances from three customers that accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 92</font>% of trade receivables at December 31, 2014.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7066137 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7066137 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7048235 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7048235 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7048235 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7048235 shares
CY2015Q1 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
CY2015Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2013-07-15
CY2015Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
637610 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
494659 USD
CY2014Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
263142 USD
CY2015Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
154805 USD
CY2014Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
48280 USD
CY2015Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
178451 USD
CY2014Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
183237 USD
CY2014Q1 us-gaap Revenues
Revenues
291095 USD
CY2014Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
194341 USD
CY2014Q1 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
202883 USD
CY2015Q1 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
0 USD
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
397224 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
-106129 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
744968 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
1322750 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1428879 USD
CY2014Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8137 USD
CY2015Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4473 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-1420742 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6999105 shares
CY2014Q4 ipwr Trade Receivables Current
TradeReceivablesCurrent
231412 USD
CY2015Q1 us-gaap Grants Receivable Current
GrantsReceivableCurrent
0 USD
CY2014Q4 us-gaap Other Receivables
OtherReceivables
107657 USD
CY2015Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
833470 USD
CY2014Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
471296 USD
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
24775 USD
CY2015Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
114130 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
143289 USD
CY2015Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
119831 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
148752 USD
CY2015Q1 us-gaap Inventory Gross
InventoryGross
233961 USD
CY2014Q4 us-gaap Inventory Gross
InventoryGross
292041 USD
CY2015Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 USD
CY2014Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
40703 USD
CY2015Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
304354 USD
CY2015Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1055580 USD
CY2014Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1040219 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
31812 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
27255 USD
CY2015Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
718262 USD
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
141137 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
120283 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
548953 USD
CY2015Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
209380 USD
CY2014Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
143364 USD
CY2015Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
89587 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
80802 USD
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3493360 USD
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y1M6D
CY2015Q1 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
117813 USD
CY2015Q1 us-gaap Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
159941 USD
CY2015Q1 us-gaap Other Commitment Due In Third Year
OtherCommitmentDueInThirdYear
163489 USD
CY2015Q1 us-gaap Other Commitment Due In Fourth Year
OtherCommitmentDueInFourthYear
68736 USD
CY2015Q1 us-gaap Other Commitment
OtherCommitment
509979 USD
CY2015Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
54211 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9084 USD
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32803 USD
CY2014Q1 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2015Q1 us-gaap Inventory Write Down
InventoryWriteDown
-16454 USD
CY2014Q1 us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
0 USD
CY2015Q1 us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
69482 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
188574 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
353159 USD
CY2014Q1 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
33960 USD
CY2015Q1 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
25470 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
87973 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
386949 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12058 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-33831 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
34498 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
485 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-216955 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
245768 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-985 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
244110 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1517477 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1592263 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
37259 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
150343 USD
CY2014Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
137809 USD
CY2015Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
84843 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-175068 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-235186 USD
CY2014Q1 ipwr Proceeds From Payments For Exercise Of Options And Warrants
ProceedsFromPaymentsForExerciseOfOptionsAndWarrants
-9 USD
CY2015Q1 ipwr Proceeds From Payments For Exercise Of Options And Warrants
ProceedsFromPaymentsForExerciseOfOptionsAndWarrants
84813 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-9 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
84813 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1692554 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1742636 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14137097 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12444543 USD
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.48
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
24775 USD
CY2015Q1 ipwr Shares Issued On Exercise Of Warrants
SharesIssuedOnExerciseOfWarrants
0 shares
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
Ideal Power Inc.
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001507957
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q1 dei Trading Symbol
TradingSymbol
IPWR
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7084953 shares
CY2015Q1 us-gaap Inventory Adjustments
InventoryAdjustments
26624 USD
CY2015Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1564108 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1564108 shares
CY2015Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.48

Files In Submission

Name View Source Status
0001144204-15-027790-index-headers.html Edgar Link pending
0001144204-15-027790-index.html Edgar Link pending
0001144204-15-027790.txt Edgar Link pending
0001144204-15-027790-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ipwr-20150331.xml Edgar Link completed
ipwr-20150331.xsd Edgar Link pending
ipwr-20150331_cal.xml Edgar Link unprocessable
ipwr-20150331_def.xml Edgar Link unprocessable
ipwr-20150331_lab.xml Edgar Link unprocessable
ipwr-20150331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpg15.jpg Edgar Link pending
v409135_10q.htm Edgar Link pending
v409135_ex31-1.htm Edgar Link pending
v409135_ex31-2.htm Edgar Link pending
v409135_ex32-1.htm Edgar Link pending